Clinical Trial Update: Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update covers a Phase 1 study evaluating hydroxyurea plus combination chemotherapy in patients with non-small cell lung cancer. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Ottawa Regional Cancer Centre | Conditions: Lung Cancer | Phase 1 | Status: UNKNOWN